The Pharmaceutical Security Institute (psi)
The Pharmaceutical Security Institute (PSI) is a not-for-profit membership organization founded in 2002 that operates the Counterfeiting Incident System (CIS) to track pharmaceutical counterfeiting, theft, and illegal diversion across 136 countries for its over 40 major international pharmaceutical manufacturer members.
- Company typePrivate
- Founded2002
- HeadquartersAlexandria, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What The Pharmaceutical Security Institute (psi) does
The Pharmaceutical Security Institute (PSI) is a not-for-profit, membership-based organization founded in 2002 by Security Directors of fourteen major pharmaceutical companies in Washington, D.C., now headquartered in Alexandria, Virginia. PSI's core mission is to protect public health by collecting and sharing information on pharmaceutical counterfeiting, theft, and illegal diversion, and by initiating enforcement actions through appropriate authorities. The organization operates a proprietary Counterfeiting Incident System (CIS) that has continuously recorded pharmaceutical crime incidents for 23 years, drawing on open media reports, member company submissions, and public-private sector partnerships. In CY 2024 alone, the CIS documented 6,424 incidents across 136 countries, involving 2,248 different medicines and 3,658 arrests.
PSI's membership is limited to major international pharmaceutical manufacturers — currently over 40 organizations — and the organization is funded through membership dues rather than venture or equity capital. The organization distributes intelligence to members and, through its collaboration with the Partnership for Safe Medicines (PSM), to consumers via tools such as the SafeMeds Alert System, SAFEDRUG Checklist, and a YouTube channel. Beyond its Alexandria headquarters, PSI maintains representational offices with staff in Singapore (Asia Pacific) and Dublin, Ireland (Europe), enabling regional engagement with members, regulators, and law enforcement. The organization has no disclosed revenue figures, no disclosed headcount, and operates a public Report Medicines portal as an additional data ingestion channel for consumers, customs officials, drug inspectors, and police officers.
The Pharmaceutical Security Institute (psi) firmographics
Firmographics- Name
- The Pharmaceutical Security Institute (psi)
- Legal name
- Pharmaceutical Security Institute
- Website
- https://psi-inc.org
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The Pharmaceutical Security Institute (PSI) is a not-for-profit membership organization founded in 2002 that operates the Counterfeiting Incident System (CIS) to track pharmaceutical counterfeiting, theft, and illegal diversion across 136 countries for its over 40 major international pharmaceutical manufacturer members.
- Ownership category
- akta.pro rank
The Pharmaceutical Security Institute (psi) industry classification
Industry- Product category
- Pharmaceutical Crime Intelligence
- NAICS
- Security Guards and Patrol Services (561612)
- SIC
- Services-Detective, Guard & Armored Car Services (7381)
- akta.pro primary industry
- Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB)
Keywords
Where The Pharmaceutical Security Institute (psi) is headquartered
LocationHeadquarters
- HQ city
- Alexandria
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
The Pharmaceutical Security Institute (psi) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Others
Distribution channels2 records
Marketing channels4 records
The Pharmaceutical Security Institute (psi) product offering
Product offeringCore offering
PSI operates a membership-based pharmaceutical crime intelligence platform centered on its proprietary Counterfeiting Incident System (CIS), which collects, tracks, and analyzes incidents of pharmaceutical counterfeiting, theft, and illegal diversion worldwide. The organization aggregates data from open media reports, member company submissions, and public-private partnerships, then shares intelligence with member pharmaceutical manufacturers and coordinates international enforcement actions with regulatory and law enforcement agencies.
Product overview
The Pharmaceutical Security Institute (PSI) is a not-for-profit membership organization that operates primarily as a pharmaceutical crime data collection and analysis entity rather than a product company in the traditional sense. Its core offering is the Counterfeiting Incident System (CIS), which tracks pharmaceutical crime incidents globally. PSI does not offer commercial software products but provides information sharing, enforcement coordination, and consumer reporting tools to its member pharmaceutical manufacturers and the general public.
Differentiator
Problem solved
Functional benefit
Products and services
- Counterfeiting Incident System (CIS) A proprietary data collection and tracking system that records incidents of counterfeiting, theft, and illegal diversion of pharmaceutical products worldwide, aggregating inputs from open media reports, PSI member company submissions, and public-private sector partnerships. Used by PSI's member pharmaceutical manufacturers and law enforcement agencies for intelligence sharing and coordinated enforcement.
- Report Medicines Portal A public reporting portal on the PSI website that allows consumers, drug inspectors, customs officials, police officers, and the general public to report counterfeit pharmaceuticals. Reports feed into the CIS database.
Quantifiable outcome
- 6,424 pharmaceutical crime incidents documented in CY 2024
- +3 more outcomes
Companies that use The Pharmaceutical Security Institute (psi)
Customer profileSegments1 record
Ideal customer profiles1 record
The Pharmaceutical Security Institute (psi) technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
The Pharmaceutical Security Institute (psi) partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Partnership for Safe Medicines (PSM)corePSI collaborates with the Partnership for Safe Medicines (PSM) to share quality information on counterfeit medicines with the public. PSM provides an impressive suite of online tools recommended to consumers including the SafeMeds Alert System and SAFEDRUG Checklist.
Scale indicators6 records
Recent moves8 records
Expansion highlights4 records
The Pharmaceutical Security Institute (psi) competitors and assessment
Company assessmentBroad incumbents
- INTERPOL: INTERPOL coordinates international law enforcement action, including operations against pharmaceutical crime (e.g., Operation Pangea targeting illicit online pharmacies). PSI coordinates with law enforcement bodies including INTERPOL counterparts to drive arrests.
- World Health Organization (WHO): WHO runs the Global Surveillance and Monitoring System for substandard and falsified medical products, which parallels PSI's CIS database at a public-sector level with a broader healthcare scope beyond pharmaceuticals.
- European Medicines Agency (EMA): EMA regulates human and veterinary medicines in the EU and coordinates member-state responses to falsified medicines, including via the EU Falsified Medicines Directive—operating as a regulator that PSI members report incidents to.
- National Association of Boards of Pharmacy (NABP): NABP operates pharmacy accreditation and verification programs (including e-Profile) used to protect the US drug supply from counterfeit and substandard medicines, operating in an adjacent regulatory space to PSI's intelligence mission.
- Pharmaceutical Research and Manufacturers of America (PhRMA): PhRMA is the broad US pharma industry trade association representing major manufacturers. PSI's membership overlaps significantly with PhRMA's constituency, and both advocate on industry safety and integrity issues.
- U.S. Food and Drug Administration (FDA): The FDA is the primary US regulator whose counterfeit drug alerts are relayed to consumers via PSI's SafeMeds Alert System. FDA is a key counterpart in PSI's enforcement coordination chain.
Direct peers
- Rx-360: Rx-360 is an international pharmaceutical supply chain consortium that shares audit and quality information among member manufacturers and suppliers. Like PSI, it is a membership-driven organization focused on pharmaceutical supply chain integrity.
- Partnership for Safe Medicines (PSM): PSM is PSI's primary public-facing partner and the most directly comparable organization, focused on educating the public and policymakers about counterfeit medicines. It amplifies PSI's intelligence to consumers via tools like the SafeMeds Alert System and SAFEDRUG Checklist.
Emerging players
- Solvay Pharma / Antares Pharma (serialization vendors example): Commercial serialization, track-and-trace, and supply-chain-security vendors (represented here by Antares as an example) increasingly offer pharmaceutical manufacturers real-time supply chain visibility—an alternative or complement to PSI's incident-based intelligence model.
- Center for Safe Internet Pharmacies (CSIP): CSIP is a coalition focused on combating illegal online pharmacies, operating in an adjacent threat space to PSI's counterfeit drug mandate with a narrower (online) scope.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
The Pharmaceutical Security Institute (psi) social profiles
Digital presenceThe Pharmaceutical Security Institute (psi) financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Pharmaceutical Security Institute (psi) leadership team
Management profileNumber of profiles
The Pharmaceutical Security Institute (psi) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Pharmaceutical Security Institute (psi) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Pharmaceutical Security Institute (psi)
What does The Pharmaceutical Security Institute (psi) do?
PSI operates a membership-based pharmaceutical crime intelligence platform centered on its proprietary Counterfeiting Incident System (CIS), which collects, tracks, and analyzes incidents of pharmaceutical counterfeiting, theft, and illegal diversion worldwide. The organization aggregates data from open media reports, member company submissions, and public-private partnerships, then shares intelligence with member pharmaceutical manufacturers and coordinates international enforcement actions with regulatory and law enforcement agencies.
Is The Pharmaceutical Security Institute (psi) a public or private company?
The Pharmaceutical Security Institute (psi) is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Pharmaceutical Security Institute (psi) founded?
The Pharmaceutical Security Institute (psi) was founded in 2002. It employs 1 to 10 people.
Where is The Pharmaceutical Security Institute (psi) based?
The Pharmaceutical Security Institute (psi) is headquartered in Alexandria, United States, in the North America region.
Who are The Pharmaceutical Security Institute (psi)'s main competitors?
Broad incumbents on record are INTERPOL, World Health Organization (WHO), European Medicines Agency (EMA), National Association of Boards of Pharmacy (NABP), Pharmaceutical Research and Manufacturers of America (PhRMA) and U.S. Food and Drug Administration (FDA). Direct peers are Rx-360 and Partnership for Safe Medicines (PSM). Emerging players are Solvay Pharma / Antares Pharma (serialization vendors example) and Center for Safe Internet Pharmacies (CSIP).
Does The Pharmaceutical Security Institute (psi) have an API?
No public API is recorded for The Pharmaceutical Security Institute (psi).
What industry is The Pharmaceutical Security Institute (psi) in?
The Pharmaceutical Security Institute (psi)'s product category is Pharmaceutical Crime Intelligence. Its primary akta.pro industry code is HLAGALAB, Safety Database Operations & Hosting (Argus/ARISg/Oracle). Its NAICS code is 561612 and its SIC code is 7381.